Robert Schotzinger
Principal investigator, leads ELDEC PHARMACEUTICALS INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2025First federal award
$1.2MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 11, 2026 | NIH | STTR Phase II Novel peptide therapeutics to treat cystic fibrosis-related diabetes | $908K | ELDEC PHARMACEUTICALS INC. |
| Sep 12, 2025 | NIH | STTR Phase II Novel peptide therapeutics to treat cystic fibrosis-related diabetes | $280K | ELDEC PHARMACEUTICALS INC. |
Peer ranks
Federal funding#1,610
Awards as PI#1,252
Patents#273
Companies
- ELDEC PHARMACEUTICALS INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.